The city of Schwerin is getting an injection of new business. Kunststoffweb reports that Swiss medical company Ypsomed has opened a new production facility in the northern German town. Ypsomed specializes in self-medication technologies and services, for example, easy-to-use delivery systems allowing diabetes sufferers to give themselves insulin shots. It also makes systems for measuring blood-sugar levels and is involved in trying to improve treatments of the disease.
In addition to production, the Schwerin facility will be used for logistical storage, quality control and technology maintenance. An expected 150 jobs will be created in the coming five years – with possibilities for expansion later on.
Ypsomed CEO Simon Michel said that his company had decided to set up shop in Schwerin to secure production capacities in anticipation of further growth. Its locations in Switzerland had no more room, Michel added.